In addition, the high expression of NEK2/3mRNA was significantly associated with poor prognosis in patients with NSCLC, while the high expression of NEK1/4/6/7/8/9/10/11 mRNA was associated with good prognosis. The gene discussed is NEK2; the disease is non-small cell lung carcinoma.